These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 14961034

  • 1. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
    Dworzak MN, Fröschl G, Printz D, Zen LD, Gaipa G, Ratei R, Basso G, Biondi A, Ludwig WD, Gadner H.
    Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
    [Abstract] [Full Text] [Related]

  • 2. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM, Verzhbitskaia TIu, Tsaur GA, Shorikov EV, Savel'ev LI, Tsvirenko SV, Fechina LG.
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [Abstract] [Full Text] [Related]

  • 3. Significance of CD99 expression in T-lineage acute lymphoblastic leukemia.
    Enein AA, Rahman HA, Sharkawy NE, Elhamid SA, Abbas SM, Abdelfaatah R, Khalil M, Fathalla LA.
    Cancer Biomark; 2016 Mar 18; 17(2):117-23. PubMed ID: 27002769
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.
    Björklund E, Mazur J, Söderhäll S, Porwit-MacDonald A.
    Leukemia; 2003 Jan 18; 17(1):138-48. PubMed ID: 12529671
    [Abstract] [Full Text] [Related]

  • 5. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB, Neiman RS, Worapongpaiboon S, John K, Orazi A.
    Mod Pathol; 1997 Apr 18; 10(4):277-82. PubMed ID: 9110287
    [Abstract] [Full Text] [Related]

  • 6. CD4 and CD8 double-negative adult T-cell leukemia/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus.
    Lin TH, Wu HC, Hsieh YC, Tseng CE, Ichinohasama R, Chuang SS.
    Pathol Int; 2013 Feb 18; 63(2):132-7. PubMed ID: 23464972
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC, Dunphy CH.
    Arch Pathol Lab Med; 2006 Feb 18; 130(2):153-7. PubMed ID: 16454553
    [Abstract] [Full Text] [Related]

  • 8. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
    Gore SD, Kastan MB, Goodman SN, Civin CI.
    J Immunol Methods; 1990 Sep 14; 132(2):275-86. PubMed ID: 1698878
    [Abstract] [Full Text] [Related]

  • 9. Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
    Tembhare PR, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Panda D, Patkar NV, Narula G, Girase K, Verma S, Sanyal M, Sriram HN, Banavali S, Gujral S, Subramanian PG.
    Cytometry B Clin Cytom; 2021 Jul 14; 100(4):421-433. PubMed ID: 32812702
    [Abstract] [Full Text] [Related]

  • 10. [The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry].
    Zhang LP, Cheng YF, Liu GL, Lu AD, Liu YR, Wang H.
    Zhonghua Er Ke Za Zhi; 2005 Jul 14; 43(7):481-5. PubMed ID: 16083543
    [Abstract] [Full Text] [Related]

  • 11. [Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression].
    Cho YU, Park CJ, Cha CH, Chi HS, Jang S, Kim MJ, Lee KH, Lee JH, Lee JH, Seo JJ, Im HJ.
    Korean J Lab Med; 2010 Dec 14; 30(6):533-9. PubMed ID: 21157135
    [Abstract] [Full Text] [Related]

  • 12. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study.
    Chowdhury S, Bandyopadhyay S, Mandal C, Chandra S, Mandal C.
    BMC Cancer; 2008 Feb 01; 8():40. PubMed ID: 18241334
    [Abstract] [Full Text] [Related]

  • 13. BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
    Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A.
    Leukemia; 2000 May 01; 14(5):816-25. PubMed ID: 10803512
    [Abstract] [Full Text] [Related]

  • 14. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, van Dongen JJ.
    Leukemia; 1993 Mar 01; 7(3):472-81. PubMed ID: 7680403
    [Abstract] [Full Text] [Related]

  • 15. Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.
    Roshal M, Fromm JR, Winter S, Dunsmore K, Wood BL.
    Cytometry B Clin Cytom; 2010 May 01; 78(3):139-46. PubMed ID: 20155852
    [Abstract] [Full Text] [Related]

  • 16. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
    Soslow RA, Zukerberg LR, Harris NL, Warnke RA.
    Mod Pathol; 1997 Aug 01; 10(8):810-7. PubMed ID: 9267824
    [Abstract] [Full Text] [Related]

  • 17. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    Xia M, Zhang H, Lu Z, Gao Y, Liao X, Li H.
    J Pediatr Hematol Oncol; 2016 Aug 01; 38(6):418-22. PubMed ID: 27438018
    [Abstract] [Full Text] [Related]

  • 18. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G, I-BFM-ALL-FCM-MRD-Study Group.
    Haematologica; 2003 Nov 01; 88(11):1245-52. PubMed ID: 14607753
    [Abstract] [Full Text] [Related]

  • 19. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
    Dorfman DM, Kraus M, Perez-Atayde AR, Barnhill RL, Pinkus GS, Granter SR.
    Mod Pathol; 1997 Apr 01; 10(4):283-8. PubMed ID: 9110288
    [Abstract] [Full Text] [Related]

  • 20. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T.
    Leukemia; 1995 Apr 01; 9(4):615-23. PubMed ID: 7723394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.